Viewing Study NCT03721068

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2026-01-25 @ 1:00 AM
Study NCT ID: NCT03721068
Status: RECRUITING
Last Update Posted: 2025-09-09
First Post: 2018-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroblastoma View
None Osteosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Autologous Chimeric Antigen Receptor (CAR) T Cells View
None Interleukin (IL)-15 View
None Disialoganglioside (GD2) View
None Caspase 9 View
None Pediatric View
None Rimiducid View
None AP1903 View
None modified T cells View
None CAR T View